Skip to main content
Home / The International Journal of Tuberculosis and Lung Disease, Volume 17, Number 3

Quality of life among people treated for tuberculosis and human immunodeficiency virus in Rio de Janeiro, Brazil [Short communication]

Buy Article:

$34.78 + tax (Refund Policy)

We measured quality of life (QOL) among individuals receiving treatment for human immunodeficiency virus (HIV; n = 45), active tuberculosis (TB; n = 44) and both TB and HIV (n = 9) in Rio de Janeiro, Brazil. Active treated TB was associated with lower physical health (absolute decrease of 0.95 standard deviation in summary score), but not mental health, among people being treated for HIV. Visual analogue scale scores were similar across all three populations, and corresponded closely to standard disability weights used in the literature. Among patients receiving treatment, those with HIV, active TB and both conditions together appear to have similar QOL.

Keywords: Brazil; human immunodeficiency virus; quality of life; tuberculosis

Document Type: Research Article

Affiliations: 1: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 2: Municipal Health Secretariat, Rio de Janeiro, Rio de Janeiro, Brazil 3: Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 4: Municipal Health Secretariat, Rio de Janeiro, Rio de Janeiro, Brazil; Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil 5: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA 6: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Municipal Health Secretariat, Rio de Janeiro, Rio de Janeiro, Brazil 7: Municipal Health Secretariat, Rio de Janeiro, Rio de Janeiro, Brazil; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Publication date: 01 March 2013

More about this publication?

  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content